Literature DB >> 14699396

A cancer immunosurveillance controversy.

Zhihai Qin, Thomas Blankenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14699396     DOI： 10.1038/ni0104-3

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  19 in total

1.  IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis.

Authors:  Shui Ping Tu; Michael Quante; Govind Bhagat; Shigeo Takaishi; Guanglin Cui; Xiang Dong Yang; Sureshkumar Muthuplani; Wataru Shibata; James G Fox; D Mark Pritchard; Timothy C Wang
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Early tumor dissemination, but late metastasis: insights into tumor dormancy.

Authors:  Martin Röcken
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 3.  Targeting cancer-specific mutations by T cell receptor gene therapy.

Authors:  Thomas Blankenstein; Matthias Leisegang; Wolfgang Uckert; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2015-02-27       Impact factor: 7.486

Review 4.  The determinants of tumour immunogenicity.

Authors:  Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2012-03-01       Impact factor: 60.716

Review 5.  The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells.

Authors:  Bong Ihn Koh; Yibin Kang
Journal:  EMBO Rep       Date:  2012-05       Impact factor: 8.807

6.  Multifaceted tumor stromal fibroblasts.

Authors:  Jie Li; Lin Chen; Zhihai Qin
Journal:  Cancer Microenviron       Date:  2012-05-25

Review 7.  A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.

Authors:  T H Schreiber; E R Podack
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

Review 8.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Authors:  David H Raulet; Nadia Guerra
Journal:  Nat Rev Immunol       Date:  2009-08       Impact factor: 53.106

9.  Fas expression by tumor stroma is required for cancer eradication.

Authors:  Joanna J Listopad; Thomas Kammertoens; Kathleen Anders; Bjoern Silkenstedt; Gerald Willimsky; Karin Schmidt; Anja A Kuehl; Christoph Loddenkemper; Thomas Blankenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

10.  The immune microenvironment of human tumors: general significance and clinical impact.

Authors:  Wolf-Herman Fridman; Marie-Caroline Dieu-Nosjean; Franck Pagès; Isabelle Cremer; Diane Damotte; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Cancer Microenviron       Date:  2012-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.